Protein-based artificial retina
Eye implant made of light-sensitive protein to restore sight
LambdaVision
Connecticut biotech developing a protein-based artificial retina for people blinded by retinal disease. It is developing a way to build the retina's thin protein layers in microgravity and has flown that work to the ISS nine times. (1 product in the atlas)
Products, by altitude
Low Earth orbit · 160–2,000 km
Testing
Known rounds
| Date | Round | Amount | Led by |
|---|---|---|---|
| Nov 2025 | Seed | $7M | Seven Seven Six, Aurelia Foundry Fund1 |
Milestones
- Jun 2026 LambdaVision signed a memorandum of understanding with Vast covering future research and manufacturing aboard Vast's planned Haven-1 and later commercial space stations. Company statement2
- Feb 2026 LambdaVision booked research and manufacturing time on the planned Starlab commercial space station with Starlab Space and Voyager Technologies. Company statement3
- Sep 2025 LambdaVision received a NASA Phase 2 In Space Production Applications (InSPA) award to advance manufacturing in low Earth orbit. Company statement4
Sources
Updated Oct 22, 2026 · How we source facts · Suggest a correction